Add BrightSurf on Google Email

Researchers revolutionize RNA detection

Researchers developed a new diagnostic test, CAARRD, to detect ribonucleic acid (RNA) at room temperature, increasing sensitivity and reducing complexity. The test uses special 'anti-tag' CRISPR sequences to block the activity of the Cas13a enzyme, allowing for faster and more affordable detection of viral RNAs such as HIV.

SourceUniversity of Connecticut·JournalNature Communications·DateOct 16, 2025

Safer, more effective vaccines with new mRNA vaccine technology

Researchers have developed a new mRNA vaccine technology using albumin-recruiting lipid nanoparticles to deliver vaccines precisely to lymph nodes, avoiding liver toxicity. The approach outperformed traditional delivery systems in laboratory tests, producing strong antitumor T-cell responses and high levels of neutralizing antibodies.

NUS Medicine researchers develop fat-like nanoparticles to treat fatty liver disease

Researchers developed a novel RNA-based therapy using lipid nanoparticles to silence a gene causing ceramide buildup in the liver, reducing inflammation and scarring. The treatment shows promise for millions of patients worldwide and could eventually benefit those with heart disease, obesity, and diabetes.

Simultaneous synthesis of all 21 types of tRNA in vitro

Scientists have created a novel method to synthesize all 21 types of transfer RNA (tRNA) simultaneously in a test tube using the tRNA array method. This breakthrough allows for precise control over protein synthesis and has significant implications for the development of artificial molecular systems with self-reproducing capabilities.

Cellular quality control in humans decoded

Researchers have developed a system to selectively switch off the key molecule of NMD, allowing them to observe its function in human cells with unprecedented precision. The study reveals that NMD not only prevents errors but also acts as an important regulator of gene activity.

SourceUniversity of Cologne·JournalMolecular Cell·TypeExperimental study·DateSep 11, 2025

Triggering RNA activation on demand

Researchers have devised a method to safely and temporarily 'switch off' and then 'turn on' ribonucleic acid (RNA) inside cells using disulfide-containing chemical groups. This strategy could potentially open new avenues in more precise RNA-based therapeutics and gene editing.

SourceNational University of Singapore·JournalAngewandte Chemie International Edition·TypeExperimental study·DateSep 10, 2025

SMART researchers develop first-of-its-kind RNA tool to advance cancer and infectious disease research and treatment

Researchers at SMART Alliance for Research and Technology developed a powerful tool to scan thousands of biological samples and detect transfer ribonucleic acid (tRNA) modifications, which help control cell growth and response to diseases. The tool opens up new possibilities for disease research, diagnostics, and treatment development.

SourceSingapore-MIT Alliance for Research and Technology (SMART)·JournalNucleic Acids Research·TypeExperimental study·DateSep 3, 2025

How proteins bind to RNA: the dual mechanism of zinc fingers and disordered regions

Researchers discovered that disordered regions enhance specific RNA interactions in FUS protein-RNA complexes, revealing a breakthrough strategy for nucleic acid binding. The study suggests that intrinsically disordered regions actively contribute to the RNA-binding mechanism.

SourceInstitute of Science Tokyo·JournalJournal of Chemical Information and Modeling·TypeComputational simulation/modeling·DateAug 28, 2025

Long-standing mystery in molecular biology solved: Cells measure RNA tails with a molecular stopwatch

Cells use a stopwatch-like mechanism to measure the length of messenger RNA (mRNA) tails, achieving molecular accuracy in vital processes like gene expression. The discovery reveals that two proteins, CPAC and Nab2, set the tail's length by timing their interaction, with the final length determined by a race between their speeds.

SourceUniversity of Turku·JournalGenes & Development·DateAug 28, 2025

Promising new method could treat inherited diseases

Researchers at the University of Waterloo have developed a novel method using modified M13 bacteria to deliver targeted gene therapies for genetic disorders. This approach shows promise as a cost-effective alternative to current methods, which can be expensive and trigger toxic side effects.

SourceUniversity of Waterloo·JournalMolecular Therapy — Nucleic Acids·TypeExperimental study·DateAug 20, 2025

How AI could speed the development of RNA vaccines and other RNA therapies

Researchers used machine-learning models to design nanoparticles that can deliver RNA to cells more efficiently. The approach accelerated the identification of optimal ingredient mixtures in lipid nanoparticles, leading to better delivery vehicles for RNA vaccines and mRNA therapies. This could dramatically speed up the development of ...

SourceMassachusetts Institute of Technology·JournalNature Nanotechnology·DateAug 15, 2025

Synthetic engineering of telomerase RNA, development of polygenic scores paves way to better understanding of telomeres

Researchers at Boston Children's Hospital have developed a new approach to lengthening telomeres using synthetic RNA. The technique, known as eTERC, has been shown to increase telomere length in human stem cells and leave normal cell mechanisms intact. Additionally, polygenic scores have been developed to estimate the combined effect o...

SourceBoston Children's Hospital·JournalJournal of Clinical Investigation·DateAug 14, 2025

ISGlobal develops a bioinformaticstool to boost omics data analysis in precision medicine

HTGAnalyzer is an automated tool simplifying complex transcriptomic workflows, enabling clinicians without bioinformatics expertise to perform essential analyses in precision medicine. The tool has been validated using multiple datasets and identified differentially expressed genes linked to cancer diagnosis, treatment, and prognosis.

SourceBarcelona Institute for Global Health (ISGlobal)·JournalComputers in Biology and Medicine·DateAug 8, 2025

RNA immunity: An overlooked antiviral defense in mammals

Emerging evidence highlights the involvement of extracellular RNAs in the antiviral defense process, with microRNAs binding viral genomes via base-pairing interactions to inhibit expression. RNA immunity represents a complementary arm of the mammalian immune system, functionally independent of traditional protein-based defenses.

SourceScience China Press·JournalScience Bulletin·DateAug 7, 2025

Characterizing antibodies targeting antisense oligonucleotide modifications

Researchers validated panels of antibodies targeting clinically relevant nucleic acid modifications to visualize antisense oligonucleotides in both in vitro and in vivo studies. The tools enable detection of modified nucleic acids irrespective of sequence, facilitating multiple clinical and pre-clinical workflows.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalNucleic Acid Therapeutics·TypeExperimental study·DateJul 31, 2025

Where did RNA come from?

Researchers found that ribose binds to phosphate more quickly and effectively than other sugar molecules, which could have helped select it for inclusion in RNA development. The study also showed that ribose produces a five-member ring form, similar to the forms seen in RNA and DNA today.

SourceScripps Research Institute·JournalAngewandte Chemie·DateJul 21, 2025

Less pain, more gain: A new recipe for safer, stronger mRNA vaccines

Researchers at the University of Pennsylvania designed a new recipe for mRNA vaccines by adding phenol groups, which reduce inflammation and improve vaccine effectiveness. The modified lipids improved vaccine performance in various diseases, including COVID-19, cancer, and genetic diseases, with enhanced efficacy and reduced side effects.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Biomedical Engineering·TypeExperimental study·DateJul 18, 2025

KAIST develops technology for selective RNA modification in living cells and animals

Researchers at KAIST have developed a groundbreaking technology capable of selectively acetylating specific RNA molecules within the human body using the CRISPR-Cas13 system. This breakthrough enables precise, programmable control of RNA function and is expected to open new avenues in RNA-based therapeutic development.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalNature Chemical Biology·TypeExperimental study·DateJun 11, 2025

A quick end for mRNA

Researchers at the University of Würzburg have discovered a new degradation process for mRNA that targets proteins involved in cell differentiation. This process, triggered by the m6A modification, is significantly faster and more efficient than previously known mechanisms.

SourceUniversity of Würzburg·JournalMolecular Cell·DateDec 16, 2024

3D snapshots unveil the intricate dance of RNA folding

Scientists have captured 3D snapshots of individual RNA nanoparticles in motion, showcasing the dynamic and intricate folding process. This breakthrough uses advanced electron microscopy to study RNA's flexibility, enabling new insights into its structure and potential applications in molecular medicine.

SourceAarhus University·JournalNature Communications·TypeExperimental study·DateNov 25, 2024